Biomarker-based Study in R/M SCCHN

Condition:   Carcinoma, Squamous Cell of Head and Neck
Interventions:   Drug: Afatinib;   Drug: Palbociclib;   Drug: IPH2201;   Drug: standard of care
Sponsor:   European Organisation for Research and Treatment of Cancer - EORTC
Not yet recruiting - verified March 2017

http://ift.tt/2mVxUp6